Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC decreased its position in Bath & Body Works, Inc. (NYSE:BBWI) by 63.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 322,765 shares of the company’s stock after selling 554,802 shares during the quarter. Los Angeles Capital Management LLC owned 0.14% of Bath & Body Works worth $13,931,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in Bath & Body Works by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 25,689,543 shares of the company’s stock worth $868,307,000 after acquiring an additional 67,920 shares in the last quarter. Darsana Capital Partners LP acquired a new stake in Bath & Body Works during the third quarter valued at approximately $76,050,000. Charles Schwab Investment Management Inc. lifted its holdings in Bath & Body Works by 1.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,925,647 shares of the company’s stock worth $65,087,000 after buying an additional 27,627 shares during the last quarter. Alua Capital Management LP grew its position in shares of Bath & Body Works by 30.2% in the 3rd quarter. Alua Capital Management LP now owns 1,693,200 shares of the company’s stock worth $57,230,000 after acquiring an additional 392,800 shares in the last quarter. Finally, Earnest Partners LLC increased its holdings in shares of Bath & Body Works by 1,055,015.7% in the 3rd quarter. Earnest Partners LLC now owns 1,276,690 shares of the company’s stock valued at $43,152,000 after acquiring an additional 1,276,569 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Wall Street Analyst Weigh In

BBWI has been the topic of several research analyst reports. Piper Sandler raised their price objective on Bath & Body Works from $44.00 to $45.00 and gave the stock a “neutral” rating in a research note on Tuesday, April 9th. Evercore ISI lifted their price target on shares of Bath & Body Works from $30.00 to $45.00 and gave the company an “in-line” rating in a report on Friday, March 1st. Telsey Advisory Group reiterated an “outperform” rating and set a $53.00 price objective on shares of Bath & Body Works in a research note on Friday, April 5th. UBS Group raised their target price on shares of Bath & Body Works from $46.00 to $52.00 and gave the stock a “neutral” rating in a report on Monday, March 4th. Finally, BMO Capital Markets upped their target price on Bath & Body Works from $48.00 to $50.00 and gave the company an “outperform” rating in a report on Friday, March 1st. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $46.73.

Insider Activity

In other news, insider Thomas E. Mazurek sold 4,285 shares of the firm’s stock in a transaction dated Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total transaction of $209,493.65. Following the completion of the transaction, the insider now owns 45,992 shares in the company, valued at approximately $2,248,548.88. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.19% of the stock is owned by insiders.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI traded up $2.14 on Friday, hitting $45.97. The company’s stock had a trading volume of 2,585,013 shares, compared to its average volume of 2,601,801. Bath & Body Works, Inc. has a 12 month low of $27.30 and a 12 month high of $50.34. The stock’s 50-day moving average is $46.07 and its two-hundred day moving average is $41.03. The company has a market capitalization of $10.34 billion, a price-to-earnings ratio of 11.94, a price-to-earnings-growth ratio of 1.42 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.21. The firm had revenue of $2.91 billion during the quarter, compared to analyst estimates of $2.84 billion. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. Bath & Body Works’s revenue was up .8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.86 EPS. Equities analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 8th. Shareholders of record on Friday, February 23rd were paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 1.74%. The ex-dividend date was Thursday, February 22nd. Bath & Body Works’s payout ratio is currently 20.78%.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.